AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in AN2 Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −2 vs. Q3 2022
- Shares held
- 9.76M
- +265.8K (+2.8%) vs. Q3 2022
- Total value
- $92.9M
- −$72.1M (−43.7%) vs. Q3 2022
- New holders
- 5
- 23 more added
- Sold out
- 7
- 3 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 3,773,517 | $36.0M | 0.73% | 00.0% | Unchanged |
| BVF Inc | 1,563,963 | $14.9M | 0.63% | −52,702−3.3% | Reduced |
| Citadel Advisors LLC | 1,336,983 | $12.7M | 0.01% | 00.0% | Unchanged |
| Avidity Partners Management LP | 743,600 | $7.09M | 0.17% | +970+0.1% | Added |
| Vanguard Group Inc | 589,400 | $5.62M | 0.00% | +404,946+219.5% | Added |
| Monashee Investment Management LLC | 450,000 | $4.29M | 1.85% | +216,670+92.9% | Added |
| BlackRock Inc. | 445,209 | $4.24M | 0.00% | +256,924+136.5% | Added |
| Citigroup Inc | 134,548 | $1.28M | 0.00% | +30.0% | Added |
| Geode Capital Management, LLC | 123,085 | $1.17M | 0.00% | +39,794+47.8% | Added |
| Woodline Partners LP | 107,300 | $1.02M | 0.01% | +31,155+40.9% | Added |
| State Street Corp | 91,022 | $867.4K | 0.00% | +37,341+69.6% | Added |
| Northern Trust Corp | 80,818 | $770.2K | 0.00% | +43,379+115.9% | Added |
| UBS Group AG | 51,455 | $490.4K | 0.00% | +22,348+76.8% | Added |
| Alyeska Investment Group, L.P. | 48,426 | $461.5K | 0.00% | −57,292−54.2% | Reduced |
| Morgan Stanley | 41,305 | $393.6K | 0.00% | +1,072+2.7% | Added |
| Bank of New York Mellon Corp | 30,860 | $294.1K | 0.00% | +17,279+127.2% | Added |
| Barclays PLC | 30,058 | $286.5K | 0.00% | +2,780+10.2% | Added |
| Charles Schwab Investment Management Inc | 24,898 | $237.3K | 0.00% | +14,709+144.4% | Added |
| Bank of America Corp | 24,714 | $235.5K | 0.00% | +11,548+87.7% | Added |
| Nuveen Asset Management, LLC | 15,065 | $144.0K | 0.00% | +15,065 | New |
| Rhumbline Advisers | 10,082 | $96.0K | 0.00% | +10,082 | New |
| JPMorgan Chase & Co | 6,264 | $60.0K | 0.00% | +3,640+138.7% | Added |
| New York State Common Retirement Fund | 5,825 | $55.5K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 5,255 | $50.1K | 0.00% | +2,976+130.6% | Added |
| Deutsche Bank AG | 4,789 | $45.6K | 0.00% | +2,903+153.9% | Added |
| California State Teachers Retirement System | 4,436 | $42.3K | 0.00% | +2,541+134.1% | Added |
| STRS Ohio | 2,300 | $21.0K | 0.00% | +2,300 | New |
| Amalgamated Bank | 1,852 | $18.0K | 0.00% | +452+32.3% | Added |
| Royal Bank of Canada | 1,751 | $17.0K | 0.00% | +1,692+2,867.8% | Added |
| Legal & General Group Plc | 1,166 | $11.1K | 0.00% | +775+198.2% | Added |
| Tower Research Capital LLC (TRC) | 856 | $8.00K | 0.00% | −423−33.1% | Reduced |
| Ameritas Investment Partners, Inc. | 348 | $3.48K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 251 | $2.39K | 0.00% | +235+1,468.8% | Added |
| Advisor Group Holdings, Inc. | 200 | $2.00K | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 11,008 | $105 | 0.00% | +11,008 | New |
| Nisa Investment Advisors, LLC | 10 | $0 | 0.00% | +10 | New |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −716,538−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −17,219−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,827−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −5,726−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −26−100.0% | Sold out |